Roche Holding AG
LSE:0TDF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Roche Holding AG
LSE:0TDF
|
CH |
|
Kellogg Co
NYSE:K
|
US |
|
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
|
US |
|
Iron Mountain Inc
NYSE:IRM
|
US |
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
Oppein Home Group Inc
SSE:603833
|
CN |
|
James Hardie Industries PLC
ASX:JHX
|
IE |
|
Bank Mandiri (Persero) Tbk PT
IDX:BMRI
|
ID |
|
M
|
Mon Courtier Energie SAS
PAR:ALMCE
|
FR |
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
IN |
|
E
|
Ever Glory United Holdings Ltd
SGX:ZKX
|
SG |
|
C
|
Cameco Corp
NYSE:CCJ
|
CA |
|
P
|
Pantheon Infrastructure PLC
LSE:PINT
|
UK |
|
Glencore PLC
LSE:GLEN
|
CH |
|
Corning Inc
NYSE:GLW
|
US |
|
F
|
Frasers Property Thailand Industrial Freehold & Leasehold REIT
SET:FTREIT
|
TH |
|
KGHM Polska Miedz SA
WSE:KGH
|
PL |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
CN |
|
New China Life Insurance Co Ltd
OTC:NWWCF
|
CN |
|
H
|
Hochtief AG
SWB:HOT
|
DE |
|
STAG Industrial Inc
NYSE:STAG
|
US |
|
Oracle Corp
NYSE:ORCL
|
US |
|
Domtar Corp
TSX:UFS
|
US |
|
Z
|
Zevra Therapeutics Inc
NASDAQ:ZVRA
|
US |
Wall St Price Targets
0TDF Price Targets Summary
Roche Holding AG
According to Wall Street analysts, the average 1-year price target for 0TDF is 58.64 USD with a low forecast of 37.1 USD and a high forecast of 71.76 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0TDF's stock price target?
Price Target
58.64
USD
According to Wall Street analysts, the average 1-year price target for 0TDF is 58.64 USD with a low forecast of 37.1 USD and a high forecast of 71.76 USD.
What is the Revenue forecast for Roche Holding AG?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Roche Holding AG?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 3 years is 6%.
What is the Net Income forecast for Roche Holding AG?
Projected CAGR
14%
Over the last 14 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 3 years is 14%.
